What you will learn
- Module 1: How pharmacogenomic testing can support the healthcare system in providing the right medical treatment, to the right patient, in the right dose, at the right time.
- Module 2: Legal aspects in relation to ethics and GDPR.
- Module 3: How pharmacogenomic data can be translated and applied in the clinic. And the internationally peer-reviewed pharmacogenetic databases, treatment guidelines and regulatory framework that will guide your way.
- Module 4: Factors beyond pharmacokinetics and pharmacodynamics, e.g. how genetic variation can help shed light on different responses to drugs between patients.
- Module 5: The analytical aspects in the laboratory: what is the laboratory process flow? How is the genotype translated into the phenotype? What are the limitations and advantages of several platforms?
- Module 6: Pharmacogenomics is not something in the future – it is here today. Patients can already benefit from personalised medicine, e.g. capecitabine/DPYD, clopidogrel/CYP2C19, antidepressants/CYP2D6, pain/CYP2D6 and more.
- Module 7: Pharmacogenomics is only one factor that affects the dose-response relationship of drugs. Co-medication, kidney function, lifestyle etc. are well-known contributors affecting the dose-response relationship of drugs.
What your company will get
- An employee with an understanding of personalised medicine in relation to pharmacogenomics, pharmacokinetics and pharmacodynamics, legal aspects, regulatory framework and clinical utility.